Argus Reiterates Focus-List Buy On Celgene Following Q1 Results
May 18, 2016 at 09:24 AM EDT
Celgene Corporation (NASDAQ: CELG) reported robust 1Q results. Argus’ David Toung maintained a Focus-List Buy rating for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.